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INTRODUCTION
============

Metabolic syndrome (MetS) afflicts an estimated 69 million people in the United States, and its incidence worldwide continues to increase.[@R1]^,^[@R2] MetS is accompanied by a two-fold increased risk of cardiovascular disease (CVD) and a five-fold increased risk of type 2 diabetes.[@R3] Because MetS represents a cluster of co-occuring metabolic risk factors, differences in its definition exist. For example, the National Cholesterol Education Program Adult Treatment Panel III report (NCEP ATP III) defines MetS as having three or more of the following components: abdominal obesity, assessed by waist circumference (≥88cm for women and ≥102 cm for men); triglycerides ≥150 mg/dL; high-density lipoprotein cholesterol (HDL-C) \<50 mg/dL for women and \<40 mg/dL for men; elevated blood pressure (BP; ≥130/85 mm Hg); and fasting blood glucose ≥100 mg/dL.[@R4] On the other hand, the International Diabetes Federation included central obesity (waist circumference ≥80 cm to 88 cm for women and ≥90 cm to 102 cm for men with ethnicity-specific values) as a necessary component for diagnosis, along with any two of the four variables from the lipid, glucose, and BP profile described above.[@R5] No ethnicity-specific values were provided for any of the other four variables.

To study the efficacy of dietary modification in alleviating MetS in women, we conducted a 12-week clinical trial to investigate whether a phytochemical-rich medical food added to a Mediterranean-style low--glycemic load dietary food plan more effectively impacted MetS variables than the food plan alone. The trial (registered as NCT01010841) was completed and results published.[@R6] However, during the screening phase for enrollment, we noticed what appeared to be a racial discrepancy in plasma lipids, disproportionately disqualifying blacks from participating in the clinical trial. Therefore, we decided to examine participant data collected during the onsite screening for the clinical trial to confirm whether differences in lipid variables existed between black and white women.

SUBJECTS AND METHODS
====================

A total of 685 women in the metropolitan area of Jacksonville, Florida, responded to our advertisement for a 12-week, randomized, controlled, multicenter study. We interviewed these women over the phone to select those meeting the followin g preliminary criteria: body mass index (BMI) between 25 kg/m^2^ and 45 kg/m^2^, aged 20 to 75 years, and no use of lipid-lowering medications or supplements. Women meeting the initial criteria were invited to attend an onsite screening visit during which they provided fasting blood samples for analysis of lipid profile and glucose levels. Their BMIs were calculated, waist circumferences measured, and vital signs recorded. Method for lipid analysis has been previously published.[@R6]

Of the 281 volunteers screened on site, 27 self-identified as Asian, Hispanic, mixed race, or unknown and were excluded from the observational analysis. We analyzed the screening data from the remaining 254 women, including 116 non-Hispanic blacks and 138 non-Hispanic whites.

STATISTICAL ANALYSIS
====================

Lipid profiles, BMI, waist circumference, BP, and fasting glucose were compared between whites and blacks by using two-sided unpaired *t*-tests. Racial distribution for triglycerides ≥150 mg/dL was analyzed by a chi-square test. Triglycerides were analyzed adjusting for potential confounders (BMI, waist circumference, and BP) by using a general linear model; none of these variables had a significant influence on triglycerides levels in either blacks or whites (data not shown). Data were analyzed using SAS (software version 9.1, SAS Institute Inc, Cary, North Carolina), with the type I error set at a nominal 5%. The numerical data are reported as means ± standard error (SE), and the dichotomous data are reported as percentage based on sample size of each race.

RESULTS
=======

Racial Differences in Lipid Profiles
------------------------------------

The mean triglycerides level of blacks was significantly lower than that of whites (*P* \< .0001, [Table 1](#T1){ref-type="table"}). Triglycerides ≥150 mg/dL is the threshold for diagnosis of MetS;[@R7] only 7% of blacks vs 41% of whites had triglycerides ≥150 mg/dL (*P* \< .0001). Compared with whites, blacks also exhibited lower mean total cholesterol levels (*P* \< .0001) and LDL levels (*P* \< .001). HDL levels trended higher in blacks than in whites (*P* \> .05). However, blacks had significantly higher BMI (*P* \< .01) and diastolic BP (*P* \< .01) than whites. No significant differences were found in systolic BP, waist circumference, or fasting glucose levels between the two groups.

###### 

Cardiometabolic and Body Composition Variables of Onsite Screening Participants

                        Blacks   Whites                            
  --------------------- -------- ------------- ----- ------------- ---------
  Age (y)               116      41.2 ± 0.9    138   46.6 ± 0.8    \<.01
  BMI (kg/m^2^)         116      37.2 ± 0.5    138   35.2 ± 0.5    \<.01
  Systolic BP (mmHg)    116      127.3 ± 1.3   138   124.8 ± 1.2   NS
  Diastolic BP (mmHg)   116      82.4 ± 0.8    138   79.4 ± 0.7    \<.01
  WC (cm)               100      110.5 ± 1.2   122   108.1 ± 1.2   NS
  TC (mg/dL)            116      176.1 ± 3.6   138   201.6 ± 3.3   \<.0001
  TG (mg/dL)            116      81.1 ± 3.3    138   140.6 ± 5.9   \<.0001
  HDL (mg/dL)           116      48.2 ± 1.4    138   45.3 ± 1.2    NS
  LDL (mg/dL)           116      111.7 ± 3.3   138   128.2 ± 2.9   \<.001
  Glucose (mg/dL)       116      95.6 ± 1.9    138   97.7 ± 1.5    NS
  TC/HDL                116      3.9 ± 0.1     138   4.9 ± 0.2     \<.0001
  TG/HDL                116      1.9 ± 0.1     138   3.8 ± 0.2     \<.0001

Abbreviations: BMI, body mass index; BP, blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; NS, not significant; SE, standard error; TC, total cholesterol; TG, triglycerides; WC, waist circumference.

Blacks Exhibited Lower Total Cholesterol:High-density Lipoprotein and Triglycerides:High-density Lipoprotein Ratios
-------------------------------------------------------------------------------------------------------------------

The ratios of total cholesterol to HDL (TC:HDL) and of triglycerides to HDL (TG:HDL) are emerging biomarkers for assessing risk for heart disease; a lower ratio equates to lower risk.[@R8]^-^[@R10] Both the TC:HDL and TG:HDL ratios in blacks were significantly lower than those of whites (*P* \< .0001, [Table 1](#T1){ref-type="table"}).

Few Black Women Met Criteria for the Lipid Triad
------------------------------------------------

Grundy suggested that the combination of elevated triglycerides, increased small LDL particles, and low HDL represent increased cardiovascular risk.[@R11] A variation of the lipid triad definition posited by Bestehorn uses values from a standard lipid profile and includes the following factors[@R12]: triglycerides ≥200 mg/dL, HDL \<35 mg/dL, TC:HDL \>5. In our study, \<1% of blacks met these latter criteria for the lipid triad, and approximately 10% of whites met these criteria.

Subanalysis of Women With Waist Circumference ≥88 cm
----------------------------------------------------

Some individuals may have a high BMI without central obesity. We conducted a subanalysis in those with waist circumference ≥88 cm (n = 215), which included 84% of the blacks and 86% of the whites. Results were similar to those seen in the whole cohort with respect to significantly lower mean triglycerides, total cholesterol, and LDL, and significantly higher BMI and diastolic BP in black women ([Table 2](#T2){ref-type="table"}). However, HDL levels were significantly higher in the blacks than in whites (*P* \< .05).

###### 

Subanalysis of Clinical Data From Participants With Waist Circumference ≥88 cm

                        Blacks   Whites                            
  --------------------- -------- ------------- ----- ------------- ---------
  BMI (kg/m2)           97       37.3 ± 0.5    118   35.1 ± 0.5    \<.01
  Systolic BP (mmHg)    97       127.6 ± 1.4   118   125.1 ± 1.3   NS
  Diastolic BP (mmHg)   97       82.6 ± 0.8    118   79.3 ± 8.4    \<.01
  WC (cm)               97       111.3 ± 1.1   118   109.1 ± 1.1   NS
  TC (mg/dL)            97       176.0 ± 4.1   118   203.4 ± 3.5   \<.0001
  TG (mg/dL)            97       80.3 ± 3.5    118   147.0 ± 6.6   \<.0001
  HDL (mg/dL)           97       48.3 ± 1.5    118   44.2 ± 1.3    \<.05
  LDL (mg/dL)           97       111.7 ± 3.7   118   129.7 ± 3.0   \<.001
  Glucose (mg/dL)       97       96.0 ± 2.0    118   98.3 ± 1.7    NS
  TC/HDL                97       3.9 ± 0.1     118   5.1 ± 0.2     \<.0001
  TG/HDL                97       1.8 ± 0.1     118   4.0 ± 0.3     \<.0001

Abbreviations: BMI, body mass index; BP, blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; NS, not significant; SE, standard error; TC, total cholesterol; TG, triglycerides; WC, waist circumference.

DISCUSSION
==========

In this nested observational study, we found racial differences in lipid variables in women who were screened for a clinical trial. Black women had significantly lower levels in triglycerides, total cholesterol, and LDL but had significantly higher BMI and diastolic BP than white women. Many of these lipid variables are components of clinical guidelines that are supposed to help healthcare practitioners identify high-risk individuals. Therefore, racial differences in these variables appear to negatively impact the effectiveness of some clinical guidelines for a certain racial group, contributing to significant public health consequence.

For example, lower mean levels of triglycerides in black men and women contribute to fewer diagnoses of MetS among the black population.[@R13] Yet stroke, myocar-dial infarction, and type 2 diabetes are more frequent in the black population compared with the white population in the United States. This suggests that the standard definition of MetS is inappropriate for predicting CVD risk in the black population, and the risk goes unnoticed until disease progression has occurred. Similarly, based on Bestehorn\'s definition of lipid triad,[@R12] we observed a deceptively low CVD risk profile in black compared with white women due to racial disparities in lipid variables. Others have indicated that TC:HDL and TG:HDL ratios are useful indicators of CVD risk in overweight individuals.[@R8]^,^[@R10] However, discrepancies in both ratios between whites and blacks suggest that they are not reliable indicators of CVD risk for all populations.

Differences in enzyme activities or in lipoprotein biology may explain racial disparities in triglycerides and HDL levels. Indeed, one genotype analysis in a large cohort of black and white women indicated that genetic polymorphisms in the cholesteryl ester transfer protein gene, lipoprotein lipase gene, or hepatic lipase gene correlate with HDL levels,[@R14] and another study reported higher lipoprotein lipase mRNA levels in the subcutaneous fat of the obese blacks than of the obese whites.[@R15] Age, education, social economic status, dietary pattern, and other environmental factors also differ widely by ethnicity[@R16] and are likely contributors to the observed disparities.

Our observational study was based on a small cohort screened for a clinical trial; comprehensive data, including diet diaries, had not been collected at the screening visit. Therefore, we were not able to address whether racial differences in dietary patterns and other lifestyle factors might confound our observation. Nevertheless, a recent study based on the National Health and Nutrition Examination Surveys 1999-2006 data showed that the racial discrepancies in the MetS persisted even after adjusting for social economic status, education, physical activity, and diet quality.[@R17] We also acknowledge that there are additional limitations in this nested observational study. The cohort is not a result of random sampling, and there may be selection bias. It may not represent the general population, and the findings cannot be extrapolated to both genders and other ethnic groups.

This is not the first report on racial differences in blood lipids in a MetS study cohort; similar findings have been published in the past few years.[@R13]^,^[@R17]^-^[@R19] However, we are alarmed by the lack of awareness of this issue among numerous physicians and health-care practitioners with whom we have had personal communications. As the incidence of type 2 diabetes and heart disease continues to rise, we are faced with the dual challenge of not only managing the burden of disease but also slowing the onset of disease through preventive measures. Without guidelines that can accurately identify at-risk individuals, health-care strategies cannot be efficiently implemented. Through this brief report (and supported evidence cited in this report), we hope to renew the awareness among the medical community and *Global Advances in Health and Medicine* readers on the issue of underdiagnosis of CVD risk in blacks. We believe it is imperative to develop ethnicity-specific guidelines for MetS criteria, TC:HDL, TG:HDL, lipid triad, and even thresholds used to define hypertriglyceridemia.
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